Category Archives: Business of Biotech

Don’t Go At It Alone- BIO BizLink and the Evolving R&D Marketplace

b9e35848296c8b6718258607ece28d99

With companies in the biotechnology industry more frequently outsourcing R&D pipelines, selecting the right contract organization becomes more important. BIO, along with OnDeckBiotech, has recently launched a new online platform, BIO BizLink, that facilitates these relationships between biopharma companies and contract service providers. BIO BizLink serves as a peer-rated database for contract manufacturing organizations (CMOs) and contract research organizations (CROs) and their specific capabilities, while additionally providing secure project management tools to help companies work Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

2

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech rally after five positive years?” Moderated by Todd Foley, Managing Director, MPM Capital, the panel included: Rachel King, CEO, GlycoMimetics and Chair, BIO Ellen Lubman, VP Strategy and Innovation, Forest Laboratories Vijay Murthy, Director, Ventures and Early Stage Collaborations, AbbVie Michael A. Margolis, RPh, Managing Director, ROTH Capital Partners Doug Fambrough, PhD, CEO, Dicerna Pharmaceuticals Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

Biotech IPOs Infographic

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its passage, with nearly a tripling in the rate of companies going public in the industry. By changing how entrepreneurs can access and communicate with investors earlier in the process, the JOBS Act has fundamentally shifted how CEOs of discovery-driven companies must spend their time dealing with internal versus external priorities. Yesterday at the 2014 BIO Investor Forum, a panel of Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

lab_tech

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS, which offers $17.6 million annually through these programs, has issued a call for applications for two funding opportunities: Contract funding to support small businesses and venture-backed technology development, due Nov. 5, 2014. Investigator-initiated grant funding,due Dec. 5, 2014. NCATS’ SBIR and STTR programs are engines of innovation Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Virtual Resources: BIO BizLink Meets the C&EN Online Trade Show

BIO_BizLink_logo

For those who may not have heard, BIO recently launched a new initiative: BIO BizLink. Powered by OnDeckBiotech, BIO BizLink is a valuable resource for connecting biotech and pharma with an unparalleled community of service providers – including pre-clinical and clinical Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) and regulatory consultants. On BIO BizLink, vendors maintain a no-cost company profile, including an overview of services, reviews provided by past clients, introductions to key personnel Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,